The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract
Open accessAbstract
Psidium guajava Linn. (guava) is used not only as food but also as folk medicine in subtropical areas around the world because of its pharmacologic activities. In particular, the leaf extract of guava has traditionally been used for the treatment of diabetes in East Asia and other countries. Moreover, the anti-hyperglycemic activity of the extract has been reported in some animal models. However, little is known regarding the therapeutic activity of the extract in human clinical trials as well as its underlying therapeutic mechanisms and safety. In Japan, Guava Leaf Tea (Bansoureicha(R), Yakult Honsha, Tokyo, Japan) containing the aqueous leaf extract from guava has been approved as one of the Foods for Specified Health Uses and is now commercially available. This review describes the active component of the aqueous guava leaf extract and its inhibition of alpha-glucosidase enzymes in vitro, safety of the extract and Guava Leaf Tea, reduction of postprandial blood glucose elevation, and improvement of hyperglycemia, hyperinsulinemia, hypoadiponectinemia, hypertriglycemia and hypercholesterolemia in murine models and several clinical trials. It is suggested that the chronic suppression of postprandial blood glucose elevation is important in preventing type 2 diabetes mellitus, and that Guava Leaf Tea is considered useful as an alimentotherapy for chronic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Dose-dependent inhibition of alpha-amylase, maltase and sucrase by GvEx. Enzyme reaction was conducted for the specified time, and the amount of glucose or maltose produced was measured by HPLC. Maltase and sucrase derived from acetone powder of rat intestine, and alpha-amylase obtained from porcine pancreas were purchased from Sigma Chemical Co. (St. Louis, MO, USA) [15].](/paper-figures/bc3025aa593b4dcb9733ef6ae6618318/anti-hyperglycemic-and-anti-hyperlipidemic-effects-of-guava-leaf-extract-figure-1.jpg)
![Figure 2 Effect of single ingestion of Guava Leaf Tea on postprandial blood glucose elevation in human subjects. (a) Time course of changes in blood glucose level. (b) Area under the curve in changes in blood glucose level. Nineteen subjects aged over 40 years, with or without pre-diabetes, with an FBG level of 103.0 ± 14.3 mg/dL and a body mass index (BMI) of >22.0 were recruited. After overnight fasting for 11 hours, the subjects ingested 200 g of cooked rice as a loading carbohydrate together with a bottle (190 mL) of hot water at week 1 and then with the same volume of Guava Leaf Tea containing about 400 mg of GvEx at week 2. Blood glucose level was measured at 30-min intervals for up to 150 min after ingestion. *: p < 0.05, **: p < 0.01 (paired t-test) [15].](/paper-figures/e6d0be6f99ec4f60b023cbe785a1351e/anti-hyperglycemic-and-anti-hyperlipidemic-effects-of-guava-leaf-extract-figure-2.jpg)
![Figure 3 Effects of Guava Leaf Tea and voglibose on postprandial blood glucose elevation in patients with T2DM. Three days before and during the trial period, all patients with T2DM were treated with their usual anti-diabetic medication, namely, insulin, sulfonylurea and/or biguanide except for alpha-GI, followed by dietary treatment and/or exercise to control the FBG level at approximately 100 mg/dL. The subjects were randomized to group A or B and received their usual treatment only on day 1 (control). On day 2, the subjects in groups A and B were administered Guava Leaf Tea (200 ml) with meal and voglibose (3 mg) before meal, respectively. On day 3, the subjects were crossed-over for the administration of other treatment. The FBG and postprandial blood glucose levels were assayed before and 2 hours after meal, respectively. The combined data was analyzed using the Tukey test. **: p < 0.01, ***: p < 0.001 [27].](/paper-figures/deb2d3b78668470ea8cb5e22bd3176e7/anti-hyperglycemic-and-anti-hyperlipidemic-effects-of-guava-leaf-extract-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In metabolic syndrome, pine bark extract (150 mg/day, for 6 months) improved key risk factors: it lowered fasting glucose (~123 to ~105 mg/dL), reduced waist circumference (-7.9 cm in men and -7.3 cm in women), increased adiponectin, and reduced blood pressure and oxidative stress markers [213].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [213]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Lipid profile also improved, with reductions in LDL and triglycerides, and a rise in HDL [213,214].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [213]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“In metabolic syndrome, pine bark extract (150 mg/day, for 6 months) improved key risk factors: it lowered fasting glucose (~123 to ~105 mg/dL), reduced waist circumference (-7.9 cm in men and -7.3 cm in women), increased adiponectin, and reduced blood pressure and oxidative stress markers [213].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,516
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Wild, S. H., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2569-a · Cited by 1,477
Psidium guajava: A review of its traditional uses, phytochemistry and pharmacology
Gutiérrez, R. M. P., Mitchell, S., & Solis, R. V. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.01.025 · Cited by 937
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1992) · Medical Science Symposia Series · doi:10.1007/978-94-011-2700-4_10 · Cited by 865
Cavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569
Cited by
Antidiabetic Potential of Medicinal Plants and Their Active Components
Salehi, B., Ata, A., V. Anil Kumar, N., Sharopov, F., Ramírez-Alarcón, K., Ruiz-Ortega, A., Abdulmajid Ayatollahi, S., Valere Tsouh Fokou, P., Kobarfard, F., Amiruddin Zakaria, Z., et al. (2019) · Biomolecules · doi:10.3390/biom9100551 · Cited by 747
The phytochemistry and medicinal value of Psidium guajava (guava)
Naseer, S., Hussain, S., Naeem, N., Pervaiz, M., & Rahman, M. (2018) · Clinical Phytoscience · doi:10.1186/s40816-018-0093-8 · Cited by 349
Role of medicinal plants in the management of diabetes mellitus: a review
Jacob, B., & Narendhirakannan, R. T. (2019) · 3 Biotech · doi:10.1007/s13205-018-1528-0 · Cited by 205
Health Effects of Psidium guajava L. Leaves: An Overview of the Last Decade
Díaz-de-Cerio, E., Verardo, V., Gómez-Caravaca, A., Fernández-Gutiérrez, A., & Segura-Carretero, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040897 · Cited by 205
Giri, S. S., Sen, S. S., Chi, C., Kim, H. J., Yun, S., Park, S. C., & Sukumaran, V. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.05.051 · Cited by 192
Metadata
- Authors
- Deguchi, Y., & Miyazaki, K.
- Affiliations
- Yakult Central Institute (JP)
- Corresponding author
- Miyazaki, Kouji
- Venue
- Nutrition & Metabolism
- Published
- 2010
- Volume
- 7
- Issue
- 1
- Pages
- 9
- ISSN
- 1743-7075 (ISSN-L)
- PMC
- PMC2831039
- OpenAlex
- W2115462711
- Cited by
- 170
- References
- 42
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 16 · 2022: 14 · 2021: 12 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 12 · 2016: 8 · 2015: 11 · 2014: 15 · 2013: 5 · 2012: 8
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Nutrition & Metabolism (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Psidium guajava Extracts and Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Keywords
- guava leaf extract, guava, hypoglycemic effect, hypolipidemic effect, α-glucosidase inhibition, postprandial blood glucose, type 2 diabetes, hyperinsulinemia, hypoadiponectinemia, hypertriglyceridemia, hypercholesterolemia, aqueous leaf extract, safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. https://app.cochat.ai/papers/10.1186/1743-7075-7-9
- The paper
- Deguchi, Y., & Miyazaki, K. (2010). Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutrition & Metabolism. https://doi.org/10.1186/1743-7075-7-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.